The discovery of the immune checkpoints and their inhibitors programmed death 1 (PD-1), programmed death ligand 1 (PD-L1) and cytotoxic T-lymphocyte–associated protein 4 (CTLA-4), has improved the cancer treatment23. This evidence concerns the gene CD274 and cancer.